Juan Vera, Chief Development Officer at Marker Therapeutics, Inc. (MRKR), bought 571,428 shares at $1.75 ($1000K) on 2021-03-16, disclosed to the SEC on 2021-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALVR | SELL | 2021-02-19 | $681K | — | Filing → |
| ALVR | SELL | 2021-02-18 | $1.3M | — | Filing → |